68Ga-DOTATOC-PET/MRI and 11C-5-HTP-PET/MRI are superior to 68Ga-DOTATOC-PET/CT for neuroendocrine tumour imaging

被引:15
|
作者
Jawlakh, Hiba [1 ]
Velikyan, Irina [1 ]
Welin, Staffan [2 ]
Sundin, Anders [1 ]
机构
[1] Uppsala Univ, Dept Surg Sci Radiol & Mol Imaging, Uppsala, Sweden
[2] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
关键词
C-11-5-HTP; Ga-68-DOTATOC; detection rate; neuroendocrine tumour; PET/CT; PET/MRI; SUVmax; tumour-to-background ratio; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; ENETS CONSENSUS GUIDELINES; CONTRAST-ENHANCED CT; GA-68-DOTA-TYR(3)-OCTREOTIDE PET; BONE METASTASES; PET/MRI; MANAGEMENT; DIAGNOSIS; DOTATOC;
D O I
10.1111/jne.12981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study aimed to assess gadoxetate disodium contrast-enhanced (CE) positron emission tomography (PET)/magnetic resonance imaging (MRI) with Ga-68-DOTATOC and C-11-5-Hydroxy-tryptophan (C-11-5-HTP) in comparison with iodine CE Ga-68-DOTATOC-PET/computed tomography (CT) for neuroendocrine tumour imaging. Detection rate and reader's confidence were evaluated for each separate image volume: CE-CT, CE-MRI including diffusion-weighted imaging, Ga-68-DOTATOC-PET performed at PET/CT, Ga-68-DOTATOC-PET performed at PET/MRI and C-11-5-HTP-PET, and for the three combined hybrid examinations Ga-68-DOTATOC-PET/MRI, C-11-5-HTP-PET/MRI and Ga-68-DOTATOC-PET/CT. In 11 patients, 255 lesions were depicted. Ga-68-DOTATOC-PET performed at PET/MRI depicted 72.5%, Ga-68-DOTATOC-PET performed at PET/CT depicted 62.7%, C-11-5-HTP-PET depicted 68.2% and CE-CT depicted 53% of lesions. Ga-68-DOTATOC-PET performed at PET/MRI (P < 0.001) and PET/CT (P = 0.02), C-11-5-HTP-PET (P < 0.001) and MRI (P < 0.001) were superior to CT. Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI detected 92.5% and 92% of lesions, respectively, and both outperformed Ga-68-DOTATOC-PET/CT (65%) (P < 0.001). For liver metastasis imaging, MRI alone was unsurpassed (P < 0.01) and Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI outperformed Ga-68-DOTATOC-PET/CT (P < 0.001). For lymph node metastasis diagnosis, Ga-68-DOTATOC-PET performed at PET/MRI and PET/CT and C-11-5-HTP-PET detected 94%, 94% and 94% of lesions, respectively, and outperformed MRI and CE-CT alone (P < 0.001). For bone metastasis imaging, Ga-68-DOTATOC-PET performed at PET/MRI and PET/CT and C-11-5-HTP-PET performed equally well (P = 0.05) and better than MRI. Reader's confidence was better for Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI than for Ga-68-DOTATOC-PET/CT. The tumour maximum standardised uptake value and tumour-to-liver ratio were both approximately twice as high as for Ga-68-DOTATOC than for C-11-5-HTP. Ga-68-DOTATOC-PET/MRI and C-11-5-HTP-PET/MRI provided the highest detection rates and reader's confidence and were both superior to Ga-68-DOTATOC-PET/CT, mainly because of the MRI component. The imaging contrast with Ga-68-DOTATOC was superior to that of C-11-5-HTP.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Prognostic value of whole-body PET volumetric parameters extracted from 68Ga-DOTATOC-PET/CT in well- differentiated neuroendocrine tumors
    Thuillier, P.
    Liberini, V.
    Grimaldi, S.
    Rampado, O.
    Gallio, E.
    De Santi, B.
    Arvat, E.
    Piovesan, A.
    Filippi, R.
    Molinari, F.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S139 - S140
  • [42] [68Ga]-DOTATOC PET/CT in myocardial metastases of neuroendocrine neoplasms
    Yiraldine Herrera-Martínez
    José Luis Vercher-Conejero
    Juan José Martín-Marcuartu
    Alex Telué Vega
    Fernando Guerrero-Pérez
    Montserrat Cortés Romera
    Journal of Nuclear Cardiology, 2023, 30 : 1706 - 1708
  • [43] [68Ga]-DOTATOC PET/CT in myocardial metastases of neuroendocrine neoplasms
    Herrera-Martinez, Yiraldine
    Vercher-Conejero, Jose Luis
    Martin-Marcuartu, Juan Jose
    Telue Vega, Alex
    Guerrero-Perez, Fernando
    Cortes Romera, Montserrat
    JOURNAL OF NUCLEAR CARDIOLOGY, 2023, 30 (04) : 1706 - 1708
  • [44] Prevalence of metastases outside the liver and abdominal lymph nodes on 68Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
    Wedin, Maria
    Janson, Eva Tiensuu
    Wallin, Goran
    Sundin, Anders
    Daskalakis, Kosmas
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 (05)
  • [45] Comparison of 68Ga DOTATOC PET/CT with morphological imaging in staging of neuroendocrine tumors
    Finessi, M.
    Pilati, E.
    Passera, R.
    Liberini, V.
    De Angelis, C.
    Arvat, E.
    Birocco, N.
    Brizzi, M.
    Campra, D.
    Giraudo, G.
    Bello, M.
    Bisi, G.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S541 - S541
  • [46] 68Ga-DOTATOC vs. 68Ga-DOTATATE PET/CT in functional imaging of Neuroendocrine Tumours
    Poeppel, T. D.
    Binse, I.
    Petersenn, S.
    Lahner, H.
    Schott, M.
    Antoch, G.
    Brandau, W.
    Bockisch, A.
    Boy, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S97 - S98
  • [47] Role of 68Ga-DOTATOC PET/CT in carcinoids
    Jindal, Tarun
    Kumar, Arvind
    Kumar, Rakesh
    Dutta, Roman
    PATHOLOGY INTERNATIONAL, 2010, 60 (02) : 143 - 144
  • [48] Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
    Philippe Thuillier
    David Bourhis
    Jean Philippe Metges
    Romain Le Pennec
    Karim Amrane
    Ulrike Schick
    Frédérique Blanc-Beguin
    Simon Hennebicq
    Pierre-Yves Salaun
    Véronique Kerlan
    Nicolas Karakatsanis
    Ronan Abgral
    Scientific Reports, 11
  • [49] Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors
    Thuillier, Philippe
    Bourhis, David
    Metges, Jean Philippe
    Le Pennec, Romain
    Amrane, Karim
    Schick, Ulrike
    Blanc-Beguin, Frederique
    Hennebicq, Simon
    Salaun, Pierre-Yves
    Kerlan, Veronique
    Karakatsanis, Nicolas
    Abgral, Ronan
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT
    Wulfert, Sarah
    Kratochwil, Clemens
    Choyke, Peter L.
    Afshar-Oromieh, Ali
    Mier, Walter
    Kauczor, Hans-Ulrich
    Schenk, Jens-Peter
    Haberkorn, Uwe
    Giesel, Frederik L.
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (04) : 586 - 594